Cargando…

Implementation of Guidelines for the Management of Arterial Hypertension. The Impulsion Study

This study assessed the effects of a pilot best practice implementation enhancement program on the control of hypertension. We enrolled 697 consecutive known hypertensive patients with other vascular risk factors but free from overt vascular disease. There was no “control” group because it was consi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karagiannis, Asterios, Hatzitolios, Apostolos I, Athyros, Vasilios G, Deligianni, Kalliopi, Charalambous, Charalambos, Papathanakis, Christos, Theodosiou, Georgios, Drakidis, Theodoros, Chatzikaloudi, Veronika, Kamilali, Chysanthi, Matsiras, Sotirios, Matziris, Athanasios, Savopoulos, Christos, Baltatzi, Maria, Rudolf, Jobst, Tziomalos, Konstantinos, Mikhailidis, Dimitri P
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Open 2009
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2701277/ https://www.ncbi.nlm.nih.gov/pubmed/19557149 http://dx.doi.org/10.2174/1874192400903010026

Ejemplares similares

IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis
por: Athyros, Vasilios G., et al.
Publicado: (2011)

Dyslipidaemia of Obesity, Metabolic Syndrome and Type 2 Diabetes Mellitus: the Case for Residual Risk Reduction After Statin Treatment
por: Athyros, Vasilios G, et al.
Publicado: (2011)

Dyslipidemia Induced by Drugs Used for the Prevention and Treatment of Vascular Diseases
por: Tziomalos, Konstantinos, et al.
Publicado: (2011)

Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?
por: Athyros, Vasilios G., et al.
Publicado: (2011)

Preventing Cardio-renal Syndrome Rather than Treating It: Could Statins Play A Role?
por: Athyros, Vasilios G, et al.
Publicado: (2011)

Are we getting to lipid targets in real life?
por: Katsiki, Niki, et al.
Publicado: (2010)

Is There a Role for Hypolipidaemic Drug Therapy in the Prevention or Treatment of Microvascular Complications of Diabetes?
por: Mitsiou, Eydoxia K, et al.
Publicado: (2012)

The clinical benefit of implementing guidelines in cardiovascular disease prevention in real world settings
por: Athyros, Vasilios G., et al.
Publicado: (2012)

Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients(§)
por: Athyros, Vasilios G, et al.
Publicado: (2007)

Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study
por: Athyros, Vasilios G., et al.
Publicado: (2013)

Effects of moxonidine on sympathetic nervous system activity: An update on metabolism, cardio, and other target-organ protection
por: Karlafti, Eleni F., et al.
Publicado: (2013)

Effects of Lifestyle Measures, Antiobesity Agents, and Bariatric Surgery on Serological Markers of Inflammation in Obese Patients
por: Tziomalos, Konstantinos, et al.
Publicado: (2010)

Single-pill combinations: a therapeutic option or necessity for vascular risk treatment?
por: Katsiki, Niki, et al.
Publicado: (2013)

Off target effects of statins shape total mortality?
por: Athyros, Vasilios G., et al.
Publicado: (2016)

Differential residual dyslipidemia/cardiovascular risk after statin treatment between Asian-Indians and western whites. Call for action
por: Athyros, Vasilios Gabriel, et al.
Publicado: (2016)

Safety and impact on cardiovascular events of long-term multifactorial treatment in patients with metabolic syndrome and abnormal liver function tests: a post hoc analysis of the randomised ATTEMPT study
por: Athyros, Vassilios G., et al.
Publicado: (2011)

Is There an Association Between Carotid-Femoral Pulse Wave Velocity and Coronary Heart Disease in Patients with Coronary Artery Disease: A Pilot Study
por: Katsiki, Niki, et al.
Publicado: (2016)

Fenofibrate: a novel formulation (Triglide™) in the treatment of lipid disorders: a review
por: Tziomalos, Konstantinos, et al.
Publicado: (2006)

Acute hepatitis associated with Q fever in a man in Greece: a case report
por: Pape, Magdalini, et al.
Publicado: (2007)

Patient with Hypertriglyceridemia, Type 2 Diabetes, and Chronic Kidney Disease Treated with Atorvastatin and Omega-3 Fatty Acid Ethyl Esters
por: Athyros, Vasilios G, et al.
Publicado: (2012)

Hypokalemia induced myopathy as first manifestation of primary hyperaldosteronism - an elderly patient with unilateral adrenal hyperplasia: a case report
por: Kotsaftis, Panagiotis, et al.
Publicado: (2009)

Riedel's Lobe of the Liver: A Case Report
por: Savopoulos, Christos, et al.
Publicado: (2015)

Comparative Effect of Atorvastatin and Rosuvastatin on 25-hydroxy-Vitamin D Levels in Non-diabetic Patients with Dyslipidaemia: A Prospective Randomized Open-label Pilot Study
por: Anagnostis, Panagiotis, et al.
Publicado: (2014)

Homocysteine and carotid intima-media thickness in ischemic stroke patients are not correlated
por: Ntaios, George, et al.
Publicado: (2008)

Comparison of Premixed Human Insulin 30/70 to Biphasic Aspart 30 in Well-Controlled Patients with Type 2 Diabetes Using Continuous Glucose Monitoring
por: Margaritidis, Charalampos, et al.
Publicado: (2021)

Systemic lupus erythematosus in a patient with multiple system atrophy: A case report
por: Pilalas, Dimitrios, et al.
Publicado: (2019)

Incretin-Based Antihyperglycemic Agents for the Management of Acute Ischemic Stroke in Patients with Diabetes Mellitus: A Review
por: Milonas, Dimitrios, et al.
Publicado: (2019)

The gut microbiota in mouse models of inflammatory bowel disease
por: Gkouskou, Kalliopi K., et al.
Publicado: (2014)

Efficacy of Administration of an Angiotensin Converting Enzyme Inhibitor for Two Years on Autonomic and Peripheral Neuropathy in Patients with Diabetes Mellitus
por: Didangelos, Triantafyllos, et al.
Publicado: (2017)

A Rare Case of Lipomatous Hypertrophy of the Interventricular Septum
por: Papadopoulos, Christodoulos E., et al.
Publicado: (2016)

Effects of Sodium-Glucose Co-Transporter-2 Inhibitors on Markers of Vascular Damage
por: Kourtidou, Christodoula, et al.
Publicado: (2023)

Point of Care Ultrasonography for the Septic Patient in the Emergency Department: A Literature Review
por: Verras, Christos, et al.
Publicado: (2023)

Gut Failure: A Review of the Pathophysiology and Therapeutic Potentials in the Gut–Heart Axis
por: Matsiras, Dionysis, et al.
Publicado: (2023)

COVID-19 pandemic impact on neurologic emergencies: a single-center retrospective cohort study
por: Gavriilaki, Maria, et al.
Publicado: (2022)

A Comparative Assessment of Cardiovascular Autonomic Reflex Testing and Cardiac (123)I-Metaiodobenzylguanidine Imaging in Patients with Type 1 Diabetes Mellitus without Complications or Cardiovascular Risk Factors
por: Didangelos, Triantafyllos, et al.
Publicado: (2018)

Rectus Sheath Hematoma: A Simplified Emergency Surgical Approach
por: Mantelas, Michael, et al.
Publicado: (2011)

Drug-Induced Acute Pancreatitis in Hospitalized COVID-19 Patients
por: Paramythiotis, Daniel, et al.
Publicado: (2023)

Hepatic Fibrosis Is a Risk Factor for Greater Severity and Worse Outcome of Acute Ischemic Stroke
por: Ztriva, Eleftheria, et al.
Publicado: (2022)

Differences in Demographics, in-Hospital Management and Short-Term Prognosis in Admissions for Acutely Decompensated Heart Failure to Cardiology vs. Internal Medicine Departments: A Prospective Study
por: Bazmpani, Maria-Anna, et al.
Publicado: (2023)

Octreotide in Palliative Treatment of Hepatic Metastases: Is it Effective for Clinical Stabilization?
por: Pistevou-Gompaki, Kiki, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_4c2t6grb8paimq5c4sl94takim